141 related articles for article (PubMed ID: 33621918)
1. Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer.
Xu J; Jia Q; Zhang Y; Yuan Y; Xu T; Yu K; Chai J; Wang K; Chen L; Xiao T; Li M
Pathol Res Pract; 2021 Mar; 219():153374. PubMed ID: 33621918
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma.
Li MY; Fan LN; Han DH; Yu Z; Ma J; Liu YX; Li PF; Zhao DH; Chai J; Jiang L; Li SL; Xiao JJ; Duan QH; Ye J; Shi M; Nie YZ; Wu KC; Liao DJ; Shi Y; Wang Y; Yan QG; Guo SP; Bian XW; Zhu F; Zhang J; Wang Z
J Clin Invest; 2020 Aug; 130(8):4301-4319. PubMed ID: 32396532
[TBL] [Abstract][Full Text] [Related]
3. Effect of RSK4 on biological characteristics of colorectal cancer.
Ye Q; Wang X; Jin M; Wang M; Hu Y; Yu S; Yang Y; Yang J; Cai J
World J Surg Oncol; 2018 Dec; 16(1):240. PubMed ID: 30579335
[TBL] [Abstract][Full Text] [Related]
4. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells.
Thakur A; Sun Y; Bollig A; Wu J; Biliran H; Banerjee S; Sarkar FH; Liao DJ
Clin Cancer Res; 2008 Jul; 14(14):4427-36. PubMed ID: 18628456
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines.
Arechavaleta-Velasco F; Zeferino-Toquero M; Estrada-Moscoso I; Imani-Razavi FS; Olivares A; Perez-Juarez CE; Diaz-Cueto L
Med Oncol; 2016 Feb; 33(2):11. PubMed ID: 26732474
[TBL] [Abstract][Full Text] [Related]
6. Discovery, Optimization, and Structure-Activity Relationship Study of Novel and Potent RSK4 Inhibitors as Promising Agents for the Treatment of Esophageal Squamous Cell Carcinoma.
Yuan Y; Xu J; Jiang L; Yu K; Ge Y; Li M; He H; Niu Q; Shi X; Fan L; Chen Z; Zhao Z; Li S; Xu Y; Wang Z; Li H
J Med Chem; 2021 Sep; 64(18):13572-13587. PubMed ID: 34496560
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.
Li Q; Jiang Y; Wei W; Ji Y; Gao H; Liu J
Med Oncol; 2014 Jan; 31(1):793. PubMed ID: 24338215
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.
Dewdney SB; Rimel BJ; Thaker PH; Thompson DM; Schmidt A; Huettner P; Mutch DG; Gao F; Goodfellow PJ
Clin Cancer Res; 2011 Apr; 17(8):2120-9. PubMed ID: 21372219
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.
Arechavaleta-Velasco F; Dominguez-Lopez P; Acosta-Jimenez E; Diaz-Cueto L
Mol Biol Rep; 2023 Aug; 50(8):6863-6870. PubMed ID: 37402066
[TBL] [Abstract][Full Text] [Related]
11. Differential Expression of RSK4 Transcript Isoforms in Cancer and Its Clinical Relevance.
Chen S; Seckl MJ; Lorentzen MPG; Pardo OE
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498899
[TBL] [Abstract][Full Text] [Related]
12. Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer.
Cai J; Ma H; Huang F; Zhu D; Zhao L; Yang Y; Bi J; Zhang T
Int J Clin Exp Pathol; 2014; 7(8):4959-70. PubMed ID: 25197367
[TBL] [Abstract][Full Text] [Related]
13. RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer.
Huo H; Ye X; Yang H; Li Q; Jiang Y
Oncol Rep; 2019 Dec; 42(6):2777-2787. PubMed ID: 31545499
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mouse Rsk4 as an inhibitor of fibroblast growth factor-RAS-extracellular signal-regulated kinase signaling.
Myers AP; Corson LB; Rossant J; Baker JC
Mol Cell Biol; 2004 May; 24(10):4255-66. PubMed ID: 15121846
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types.
Dümmler BA; Hauge C; Silber J; Yntema HG; Kruse LS; Kofoed B; Hemmings BA; Alessi DR; Frödin M
J Biol Chem; 2005 Apr; 280(14):13304-14. PubMed ID: 15632195
[TBL] [Abstract][Full Text] [Related]
16. Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma.
Fan L; Li P; Yin Z; Fu G; Liao DJ; Liu Y; Zhu J; Zhang Y; Wang L; Yan Q; Guo Y; Shao C; Huang G; Wang Z
Br J Cancer; 2013 Sep; 109(5):1137-46. PubMed ID: 23942078
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
Mei Y; Liao X; Zhu L; Yang H
J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of RSK4 in breast cancer and its role in the regulation of tumorigenicity.
Jiang Y; Ye X; Ji Y; Zhou X; Yang H; Wei W; Li Q
Int J Mol Med; 2017 Sep; 40(3):883-890. PubMed ID: 28731146
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the RSK4 promoter associated with BRAF V600E promotes papillary thyroid carcinoma.
Yin Y; Che K; Hu J; Hua H; Dong A; Wang J; Yu J; Zhang Q; Zhao S; Zhao Y; Wang P; Wang F; Wang Y; Chi J; Sun W
Int J Oncol; 2020 May; 56(5):1284-1293. PubMed ID: 32319586
[TBL] [Abstract][Full Text] [Related]
20. RSK4 inhibition results in bypass of stress-induced and oncogene-induced senescence.
López-Vicente L; Pons B; Coch L; Teixidó C; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Carcinogenesis; 2011 Apr; 32(4):470-6. PubMed ID: 21239520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]